CN104544431A - 灰树花虫草饮料 - Google Patents
灰树花虫草饮料 Download PDFInfo
- Publication number
- CN104544431A CN104544431A CN201410821856.5A CN201410821856A CN104544431A CN 104544431 A CN104544431 A CN 104544431A CN 201410821856 A CN201410821856 A CN 201410821856A CN 104544431 A CN104544431 A CN 104544431A
- Authority
- CN
- China
- Prior art keywords
- drink
- parts
- grifolafrondosa
- cordyceps militaris
- xylitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001264174 Cordyceps militaris Species 0.000 title abstract description 7
- 240000001080 Grifola frondosa Species 0.000 title abstract description 6
- 235000007710 Grifola frondosa Nutrition 0.000 title abstract description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 9
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 9
- 239000000811 xylitol Substances 0.000 claims abstract description 9
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 9
- 229960002675 xylitol Drugs 0.000 claims abstract description 9
- 235000010447 xylitol Nutrition 0.000 claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 241000222684 Grifola Species 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000009413 insulation Methods 0.000 claims description 5
- 241000190633 Cordyceps Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 206010028980 Neoplasm Diseases 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 6
- 206010020772 Hypertension Diseases 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 5
- 239000000796 flavoring agent Substances 0.000 abstract description 4
- 235000019634 flavors Nutrition 0.000 abstract description 4
- 208000029078 coronary artery disease Diseases 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 208000019423 liver disease Diseases 0.000 abstract description 2
- 230000032683 aging Effects 0.000 abstract 2
- 239000000230 xanthan gum Substances 0.000 abstract 2
- 229940082509 xanthan gum Drugs 0.000 abstract 2
- 235000010493 xanthan gum Nutrition 0.000 abstract 2
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241001070941 Castanea Species 0.000 description 2
- 235000014036 Castanea Nutrition 0.000 description 2
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 240000001307 Myosotis scorpioides Species 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 2
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 102000015623 Polynucleotide Adenylyltransferase Human genes 0.000 description 1
- 108010024055 Polynucleotide adenylyltransferase Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000023819 chronic asthma Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种灰树花虫草饮料，属于保健饮料；旨在提供一种有降压解脂、保肝护心、防癌和抗衰老作用，可有效防治高血压、高血脂、肝病、冠心病、癌症等病症的饮料。它由下列重量份的原料制成：灰树花6份、北虫草1份、白砂糖或木糖醇2.5份、水50份、黄原胶0.2份，将灰树花、北虫草放入水中浸泡60分钟，加热至50-60℃、保温60-120分钟，滤液中加入上述白砂糖或木糖醇、黄原胶，搅拌均匀、灭菌。本发明具有药味少、制备简单，服用方便、无副作用等优点；长期服用能强身健体、提高肌体免疫力，有抗癌抑癌的作用，有延缓衰老、延年益寿等效果。
Description
技术领域
本发明涉及一种饮料，尤其涉及一种有有降压解脂、保肝护心、防癌和抗衰老作用的饮料。
背景技术
目前，高血压、高血脂、心脏病、肝病、癌症等病的发病率越来越高，西医对上述病症的治疗主要以消炎止痛或激素类药物为主，但存在疗程长、费用高、副作用大、疗效单一、治疗效果不理想等缺陷；目前，治疗上述病症的中药虽然很多，但同样也存在疗效单一的缺陷，而且配方复杂、疗效缓慢。
发明内容
针对现有技术中存在的上述缺陷，本发明旨在提供一种具有对高血压、高血脂有疗效，对肝炎、冠心病等心脑血管疾病有缓解作用；长期服用能强身健体、提高肌体免疫力，有抗癌抑癌的作用，有延缓衰老、延年益寿等作用的饮料。
为了实现上述目的，本发明采用以下技术方案：由下列重量份的原料制成：灰树花6份、北虫草1份、白砂糖或木糖醇2.5份、水50份、黄原胶0.2份，制备方法为：将上述灰树花、北虫草放入水中浸泡60分钟，加热至50-60℃、保温60-120 分钟，滤液中加入上述白砂糖或木糖醇、黄原胶，搅拌均匀、灭菌。
灰树花 (Grifolafrondosa)，又称贝叶多多孔菌、千佛菌、栗子磨、麻栗窝菌等，日本俗称舞茸。灰树花子实体形似盛开的莲花，香味浓郁、味道鲜美、口感极佳。同时，灰树花还有很高的营养价值和药用价值。近年来，许多国家对灰树花进行了大量而系统的研究，并有 大量报道。研究显示，灰树花中主要活性成分是灰树花蛋白多糖，多糖组分中以葡聚糖为主，含少量的木糖和甘露糖，其中已知的B-葡萄糖，尤其是D-组分，能提高人体T细胞的数量，增强机体对肿瘤的免疫力，具有明显抗肿瘤效果。综合中国、日本、加拿大、意大利、英国、美国等国家对灰树花药理研究表明，灰树花具有抗肿瘤、增强免疫的作用，并具有抗高血压，降低血糖和血脂，抗各类肝炎病毒的作用等。
蛹虫草，又名北冬虫夏草。其中的虫草酸、虫草素、虫草多糖和 SOD 等多种生物活性物质的药用价值最为显著。虫草酸 (甘露醇) 可以显著地降低颅压，促进机体新陈代谢，能使脑溢血和脑血栓病症得到缓解；虫草素是一种具有抗菌活性的核苷类物质，对核多聚腺苷酸聚合酶有很强的抑制作用，能抑制癌细胞的生长，并有降血糖的作用；虫草多糖能促进淋巴细胞转化，提高血清 IgG 的抗体含量和机体的免疫功能，可增强机体自身抗癌抑癌的能力；SOD可以消除机体内超氧自由基，具有抗衰老、抗癌抑癌的作用。此外，蛹虫草还含有丰富的硒，不仅可以明显地抑制癌细胞的生长，而且还是增强机体免疫和抗氧化能力所需的微量元素。蛹虫草的化学成分大体与冬虫夏草相同，也有低血清脂质、促进心、脑组织功能、抗炎、止咳祛痰、镇静、解痉等多种功能，可提高机体免疫功能，是一种作用面较广的免疫增强剂；同时还具有抗肿瘤作用。中医认为，虫草入肺肾二经，既能补肺阴，又能补肾阳，具有甘平保肺、益肾止血、化痰已劳嗽、秘精益气、专补命门等功效，主治肾虚、虚劳咳血、阳萎遗精、神经衰弱、盗汗自汗、腰膝疼痛、慢性咳喘、肺结核、贫血、黄胆症及老人衰弱诸症；是唯一能同时平衡、调节阴阳的中药。
与现有技术比较，本发明药味少、制备方法简单，服用方便，见效快、无副作用等优点；对高血压、高血脂有疗效，对肝炎、冠心病等心脑血管疾病有缓解作用；长期服用能强身健体、提高肌体免疫力，有抗癌抑癌的作用，有延缓衰老、延年益寿等效果。
具体实施方式 ：下面结合具体的实施例对本发明作进一步说明 ：
实施例1，将灰树花600克、北虫草100克浸泡于5000克水中60分钟，然后加热至50℃、保温120分钟，取滤液；滤液中加入白砂糖或木糖醇250克、黄原胶20克，搅拌均匀、灭菌冷却。
实施例2，将灰树花600克、北虫草100克浸泡于5000克水中60分钟，然后加热至60℃、保温60分钟，取滤液；滤液中加入白砂糖或木糖醇250 克、黄原胶20克，搅拌均匀、灭菌冷却。
实施例3，将灰树花600克、北虫草100克浸泡于5000克水中60分钟，然后加热至55℃、保温90分钟，取滤液；滤液中加入白砂糖或木糖醇250 克、黄原胶20克，搅拌均匀、灭菌冷却。
Claims (1)
1.灰树花虫草饮料，其特征在于由下列重量份的原料制成：灰树花6份、北虫草1份、白砂糖或木糖醇2.5份、水50份、黄原胶0.2份，制备方法为：将上述灰树花、北虫草放入水中浸泡60分钟，加热至50-60℃、保温60-120 分钟，滤液中加入上述白砂糖或木糖醇、黄原胶，搅拌均匀、灭菌。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410821856.5A CN104544431A (zh) | 2014-12-26 | 2014-12-26 | 灰树花虫草饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410821856.5A CN104544431A (zh) | 2014-12-26 | 2014-12-26 | 灰树花虫草饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104544431A true CN104544431A (zh) | 2015-04-29 |
Family
ID=53062352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410821856.5A Pending CN104544431A (zh) | 2014-12-26 | 2014-12-26 | 灰树花虫草饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104544431A (zh) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105286000A (zh) * | 2015-11-30 | 2016-02-03 | 福建农林大学 | 一种运动型藻粒饮料及其加工方法 |
| CN105831726A (zh) * | 2016-04-05 | 2016-08-10 | 扬州日兴生物科技股份有限公司 | 一种宜于肿瘤人群食用的含壳寡糖灰树花粉的膳食配方 |
| CN106822190A (zh) * | 2017-04-14 | 2017-06-13 | 南京圣诺生物科技实业有限公司 | 一种增强免疫力的配方、组合物及其制备方法 |
| CN109497511A (zh) * | 2018-12-03 | 2019-03-22 | 浙江养芝康生物科技有限公司 | 一种真菌提取物组合物及其在制备功能性食品和保健品中的应用 |
| CN112220805A (zh) * | 2020-10-30 | 2021-01-15 | 吉林大学 | 一种具有降血脂功能的复方制剂及制备方法 |
| CN114794343A (zh) * | 2021-01-21 | 2022-07-29 | 徐财泉 | 一种功能性灰树花复合固体饮料配方 |
| CN115176953A (zh) * | 2021-04-02 | 2022-10-14 | 徐财泉 | 一种健脾益气、补虚固本，辅助抗肿瘤的菌菇多糖配伍 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS517160A (en) * | 1974-07-05 | 1976-01-21 | Kao Corp | Kenkoinryono seizohoho |
| CN1083328A (zh) * | 1993-08-11 | 1994-03-09 | 沈阳市好猫生物技术研究所 | 北冬虫夏草保健饮料及其制备方法 |
| CN101116867A (zh) * | 2007-09-05 | 2008-02-06 | 北京交通大学 | 一种钢铝-9石墨复合板铸轧复合方法 |
| CN101810324A (zh) * | 2009-07-31 | 2010-08-25 | 李梦洋 | 虫草饮料及其加工方法 |
| CN101856371A (zh) * | 2010-07-20 | 2010-10-13 | 郭景龙 | 一种提高免疫力的药物组合物 |
| CN101889707A (zh) * | 2010-07-16 | 2010-11-24 | 大庆市帅亿生物质技术有限公司 | 虫草口服液及其制备方法 |
| CN102389139A (zh) * | 2011-09-30 | 2012-03-28 | 河北师范大学 | 一种食用菌营养保健功能性饮料的制备方法 |
| CN102726569A (zh) * | 2012-06-21 | 2012-10-17 | 何园素 | 虫草茶组合物 |
-
2014
- 2014-12-26 CN CN201410821856.5A patent/CN104544431A/zh active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS517160A (en) * | 1974-07-05 | 1976-01-21 | Kao Corp | Kenkoinryono seizohoho |
| CN1083328A (zh) * | 1993-08-11 | 1994-03-09 | 沈阳市好猫生物技术研究所 | 北冬虫夏草保健饮料及其制备方法 |
| CN101116867A (zh) * | 2007-09-05 | 2008-02-06 | 北京交通大学 | 一种钢铝-9石墨复合板铸轧复合方法 |
| CN101810324A (zh) * | 2009-07-31 | 2010-08-25 | 李梦洋 | 虫草饮料及其加工方法 |
| CN101889707A (zh) * | 2010-07-16 | 2010-11-24 | 大庆市帅亿生物质技术有限公司 | 虫草口服液及其制备方法 |
| CN101856371A (zh) * | 2010-07-20 | 2010-10-13 | 郭景龙 | 一种提高免疫力的药物组合物 |
| CN102389139A (zh) * | 2011-09-30 | 2012-03-28 | 河北师范大学 | 一种食用菌营养保健功能性饮料的制备方法 |
| CN102726569A (zh) * | 2012-06-21 | 2012-10-17 | 何园素 | 虫草茶组合物 |
Non-Patent Citations (1)
| Title |
|---|
| 李冬: "几种食用菌保健饮料加工技术", 《农产品加工》, no. 3, 31 December 2003 (2003-12-31), pages 32 * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105286000A (zh) * | 2015-11-30 | 2016-02-03 | 福建农林大学 | 一种运动型藻粒饮料及其加工方法 |
| CN105286000B (zh) * | 2015-11-30 | 2017-10-20 | 福建农林大学 | 一种运动型藻粒饮料及其加工方法 |
| CN105831726A (zh) * | 2016-04-05 | 2016-08-10 | 扬州日兴生物科技股份有限公司 | 一种宜于肿瘤人群食用的含壳寡糖灰树花粉的膳食配方 |
| CN106822190A (zh) * | 2017-04-14 | 2017-06-13 | 南京圣诺生物科技实业有限公司 | 一种增强免疫力的配方、组合物及其制备方法 |
| CN106822190B (zh) * | 2017-04-14 | 2020-12-25 | 南京圣诺生物科技实业有限公司 | 一种增强免疫力的组合物及其制备方法 |
| CN109497511A (zh) * | 2018-12-03 | 2019-03-22 | 浙江养芝康生物科技有限公司 | 一种真菌提取物组合物及其在制备功能性食品和保健品中的应用 |
| CN112220805A (zh) * | 2020-10-30 | 2021-01-15 | 吉林大学 | 一种具有降血脂功能的复方制剂及制备方法 |
| CN114794343A (zh) * | 2021-01-21 | 2022-07-29 | 徐财泉 | 一种功能性灰树花复合固体饮料配方 |
| CN115176953A (zh) * | 2021-04-02 | 2022-10-14 | 徐财泉 | 一种健脾益气、补虚固本，辅助抗肿瘤的菌菇多糖配伍 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104544431A (zh) | 灰树花虫草饮料 | |
| CN103652014B (zh) | 一种增加多糖含量的茶叶发酵方法 | |
| CN102965237B (zh) | 桑葚灵芝果酒及其生产方法 | |
| CN103653144B (zh) | 提高免疫力的保健饮料其制备方法 | |
| CN105533351A (zh) | 一种黑木耳保健饮料及其生产工艺 | |
| CN106615431B (zh) | 一种菊芋片茶及其制作方法 | |
| CN101348758B (zh) | 松花香型樱桃酒的酿制方法 | |
| CN101831369B (zh) | 金耳银杏白果黄酒、制备方法及其功效 | |
| CN102344863A (zh) | 一种木瓜酒及其制作方法 | |
| CN104522821A (zh) | 一种改善宇航员免疫力的功能果饮及其制备方法 | |
| CN104450434A (zh) | 一种生长中蛹虫草酒的制备方法及蛹虫草酒 | |
| KR101670649B1 (ko) | 한약재 발효 추출물을 함유한 혼합 조성물 및 이의 제조방법 | |
| CN105062829A (zh) | 一种高粱保健酒及其制备方法 | |
| CN105154280A (zh) | 一种特色灵芝保健酒的酿造方法 | |
| CN104382127B (zh) | 一种黑蒜蜂蜜醋饮料 | |
| CN101810324A (zh) | 虫草饮料及其加工方法 | |
| CN103937646A (zh) | 桂花风味姬松茸露酒及其制备方法 | |
| CN103039647A (zh) | 一种混合保健泡腾饮品 | |
| CN101113402B (zh) | 一种龙眼香醋的回酒制作方法 | |
| CN103571730A (zh) | 一种陈皮虫草醋及其制备方法 | |
| CN103504400A (zh) | 一种西瓜汁饮品 | |
| CN103859538A (zh) | 一种解酒护肝保健饮品的配方及加工工艺 | |
| CN105166262A (zh) | 一种滋补安神山药南瓜脯的加工方法 | |
| CN104473282B (zh) | 一种姜醋饮料及其制备方法 | |
| CN104473283B (zh) | 一种玫瑰姜醋饮料及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150429 |